‘If your fever spikes to 100.4° Fahrenheit (38° Celsius), you need to get to the ER right away.'
The World Health Organisation (WHO) has estimated that there could be 10 million deaths per year by 2050 because of drug-resistant infections.
The company's immune-based protein signature MeMed BV distinguishes between bacterial and viral infections, helping physicians determine whether antibiotic treatment is appropriate.
Researchers are hopeful tailored prescriptions can slow the evolution of antibiotic-resistant bacteria.
Researchers at the Faculties of Biology and Computer Science at the Technion-Israel Institute of Technology in Haifa have engineered a new drug that combines several different strains of antibiotics.
Antibiotic resistance can affect anyone, of any age, in any country.
"There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB," WHO director-general Dr. Tedros Ghebreyesus said.